Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P97
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Broucek, Joseph
Hughes, Tasha
Huelsmann, Erica
Lusciks, Eugene
Hill, Graham
Zayas, Janet
Poshepny, Joseph
Ruby, Carl
Kohlhapp, Frederick
Zloza, Andrew
Kaufman, Howard
Article History
First Online: 6 November 2014